Extraordinary General Meeting of Kuros Biosciences approves all resolutions

Schlieren (Zurich), Switzerland, November 29, 2018 - Kuros Biosciences (SIX: KURN) (the Company or Kuros) announces that today's Extraordinary General Meeting (EGM) approved all resolutions proposed by the Board of Directors with a clear majority. A total of 36.3% of shares was represented at the EGM.

Shareholder resolved the increase of the ordinary share capital of up to CHF4`301`464 by issuing up to 4`301`464 new ordinary shares with a nominal value of CHF 1.00 each and the creation of a conditional capital for bond s or similar instruments in the amount of CHF 1`720`585 to issue a maximum of 1`720`585 registered shares, each with a nominal value CHF1.00 and the corresponding changes in the Articles of Association.

The Extraordinary General Meeting took place at the Company`s headquarters in Schlieren. It was attended by 31 shareholders. 3.124.156 shares or 36.2% of a total 8.606.929 shares were represented.


Media Release (PDF)



Provider
Channel
Contact
Tensid EQS Ltd., Switzerland
www.tensid.ch


newsbox.ch
www.newsbox.ch


Provider/Channel related enquiries
marco@tensid.ch
+41 41 763 00 50